Journal of Science and Technology Metrics

Russian Contribution to Research on Virology: Bibliometrics Analysis, 2000-2019 on Web of Science

Valentina Markusova, Anna Zolotova
Senior Researcher, The All- Russian Institute for Scientific and Technical Information (VINITI) of the RAS, Moscow 125119, Russia *Senior Researcher, The Institute for the Study of Science of the RAS Moscow, 125119, Russia., Researcher of the VINITI of t

Abstract: The speedy development of the Russian vaccine, â€œSputnik-V,â€ created by the Gamaleya National Research Center (the Gamaleya NRC), attracted great attention worldwide. However, it resulted from many Russian scholarâ€™sâ€ contri- butions to virology research (Kramer A., 2020). This project aims to provide insights into important research development on virology through empirical analysis of Russian publications from 2000-to 2019. The metadata was retrieved from the Web of Science (WoS) Core Collection and InCites (Clarivate Anal.). The search strategy was discussed with an expert on virology. The Russian research performance (RP) growth rate was significantly higher - 290%, then the growth rate (190%) of the world dataset on virology from 2000 to 2019. The Dataset of Russian RP consisted of 6,636 records. A more detailed analysis was focused on the period 2015-2019. We selected for analysis three organizations that produced vaccines available for inoculation against COVID-19. These organizations are the Gamaleya National Research Center (the Gamaleya NRC) of the Russian Academy of Medical Sciences (RAMS), the State Research Center of Virology & Biotechnology (Vector), and the K.M.Chumakov Federal Research Center (Chumakov FRC). Among three organizations, publications of the Chumakov FRC had shown the highest value of all bibliometric indicators (nCites). The quality of publications is high: more than 69.3% of articles published in journals belonged to Q1 and Q2 quartiles. The Gamaleya NRC has the highest number of publications (394 records). Its researchers prefer to publish their results in Russian journals: the share of Q3 and Q4 journals was more than 57%. The â€œVectorâ€ is a prominent organization on new vaccine development and production (Wilson C., 2002). It is strongly focused on domestic collaboration (67.0%) compared with two other organizations and total Russian RP (29.0%). Its share (56%) of domestic collaboration is approxi- mately twice higher than its share (29.4%) of international collaboration (IC ). The leader of this collaboration was the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch (SB) of the Russian Academy of Sciences. Despite the low level of IC (19%), the USA is still the leading partner (10.8%). Funding agencies (FAs) have played an essential role in the research community in Russia since 1994. The leading FA was the Russian Science Foundation (RSF), followed by the Russian Foundation for Basic Research (RFBR) in 2015-2019. The National Institute of Health (NIH) played a significant role in Russian research on virology. The USA lost its dominance. Our results could benefit research, funding agencies, and health policy decision-makers.

Keywords: Virology, Russia, Category Normalized Citation Indicator, Highly Cited Articles, Research Productivity, Web Of Science, InCites Russian Contribution to Research on Virology: Bibliometrics Analysis, 2000-2019 on Web of Science

DOI:https://doi.org/ 10.6025/jstm/2022/3/2/47-54

Full_Text PDF () Download: 135 times

References:

[1] Adams J. (2021). Bridging the Gap – Supporting Global Engagement Strategies through Collaboration //https:// clarivatefutureresearchforum2021.virtualevent.page/day-1/
[2] Adamas, J., Potter R., Szomszor M., Pendelbery D. (2021). Global Research Report. Multi-authorship and research analytics/ / https://clarivate.com/wp-content/uploads/2021/02/ISI_-Multiauthorship_Global_Research_Report.pdf
[3] Bucci E Andreev K Björkman A et al. Safety and efficacy of the Russian COVID-19 vaccine: more information needed. Lancet. 2020; 396: e53
[4] Bucci E.M., Berkhof A., Gillibert A., Gopalakrishna G., Calogero R.A., Bouter L.M. et al. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial. Lancet (2021). DOI: https://doi.org/10.1016/S0140-6736(21)00899-0
[5] Garfield E. (1980). Premature Discovery or Delayed Recognition – Why?. Essays of an information scientist, Vol. 4. 1979– 1980. – Philadelphia, PA: ISI Press. – P. 488–493.
[6] http://garfield.library.upenn.edu/essays/v4p488y1979-80.pdf
[7] King J. (1988). The use of bibliometric technology for institutional research evaluation: a study of avian virus. Scientometrics, vol.14, N p.
[8] Kramer A. Decades-Old Soviet Studies Hint at Coronavirus Strategy
[9] https://www.nytimes.com/2020/06/24/world/europe/vaccine-repurposing-polio-coronavirus.html
[10] Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, et al. (September 4, 2020). Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formula- tions: two open, non-randomised phase 1/2 studies from Russia”. Lancet. 396 (10255): 887–897. Published online 2020 Sep 4. DOI: 10.1016/S0140-6736(20)31866-3
[11] Logunov D.Y., Dolzhikova I.V., Tukhvatullin A.I., Shcheblyakov D.V.(October, 2020)
[12] Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors” reply. Lancet ; 396 (10256): e54- e55.
[13] Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., et al. (February 20,
2021) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 397: 671-681 DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
[14] Moed H., Markusova V., Akoev M. (2018). Trends in Russian research output indexed in Scopus and Web of Science, Scientometrics. URL:https://doi.org/10.1007/s11192-018-2769-8
[15] Wilson C., Markusova V., Davis M. (2002). From Bioweapon to Biodefence: The collaborative literature on biodefense in 1990s. Scientometrics, N.1, 21-38.
[16] Zhang, L., Zhao, W., Sun, B., Huang, Y. and Glanzel, W. (2020). How scientific research reacts to international public health emergencies: a global analysis of response patterns.
[17] Scientometrics, DOI: 10.1007/s11192-020-03531-4
[18] Yaffa J. The Sputnik V Vaccine and Russia”s Race to Immunity. When the pandemic struck, scientists in Moscow set out to beat the West (2021), The New Yorker, https://www.newyorker.com/magazine/2021/02/08/the-sputnik-v-vaccine-and-russias- race-to-immunity.